Skip to main content

Halozyme Therapeutics, Inc 10-Q for FY2025 Q3

Halozyme Therapeutics, Inc. (HALO)

10-Q 2025-11-03 For: 2025-09-30
View Original
Added on April 11, 2026

About this 10-Q

Halozyme Therapeutics, Inc filed this 10-Q on November 3, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$354.26M
up 22.1% from $290.08M a year earlier
Net income
$175.23M
up 27.9% from net income of $137.01M a year earlier
Diluted EPS
$1.43
up 36.2% from $1.05 a year earlier